ForesAIt Medical Inc

ForesAIt Medical Inc

Predictive Diabetes Management Technology
Technology-Driven, Hybrid B2B · Design Stage · Ontario, Canada
Our "predictive diabetes management" technology brings proactive care and personalized analytics to diabetes patients and healthcare providers.
Elevator Pitch
There are over 30 million diabetes patients in the U.S. and Canada alone, grappling with the daily challenge of managing their blood sugar levels. Traditional methods are reactive, often leading to emergencies that could have been prevented. At foresAIt Medical Inc., we’ve pioneered predictive technology in healthcare. Our platform uses personalized machine learning and wearable tech to forecast blood sugar trends, enabling proactive management. We offer this solution directly to consumers and through B2B partnerships, transforming diabetes care into a preventive, manageable experience, enhancing patient outcomes and reducing healthcare costs.
Startup Journey
“I founded foresAIt Medical after a decade as a Biomedical Engineer, where I witnessed firsthand the predictive power of data in healthcare, using AI. Our mission became clear after engaging with over 100 diabetes patients who expressed a need for proactive management tools.

Our team, comprising experts in data science, biomedical engineering, and entrepreneurship, came together through a shared vision of improving patient outcomes. Each member brings a unique skill set, driven by personal connections to diabetes, either through family or professional experiences.

We are currently validating our predictive technology and our next goal is to set up pilot studies to understand the impact of our product. Feedback from this will help refine our approach and technology.

Execution has involved developing partnerships with healthcare providers and wearable tech companies to ensure our solutions are integrated and accessible. We’ve focused on leveraging real-time data analytics to predict blood sugar fluctuations up to 2 hours out, providing patients with actionable insights.

Currently, our greatest need is securing funding to scale our operations and extend our reach.”
Founder(s)
Ibukun Elebute
CEO/Founder
  • 10 yrs health tech experience
  • Founder of NFP Org
Daniel Echavarria
COO
  • CEO/Founder of over 4 startups
  • MBA
Revenue Forecast (USD)
2029 Revenue

$24.7m

5 Year CAGR

230%

YOY Growth - 2029

130%

2029 Year-End Rev. Run Rate

$35.2m

Earnings Forecast (USD)
2029 EBITDA

$5.7m

2029 EBITDA Margin

23%

2029 Gross Profit

$17.3m

2029 Gross Margin

70%

Investor Inquiry Form

Please fill out the below form to receive more details on the company above

Pro-Forma © 2024 All rights reserved